Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Diabetes may be linked to buildup of brain tangles associated with Alzheimer’s disease

Diabetes may be linked to buildup of brain tangles associated with Alzheimer’s disease

University of Basel scientists identify genes that play central role in development of Alzheimer's disease

University of Basel scientists identify genes that play central role in development of Alzheimer's disease

UC Santa Barbara neuroscientists uncover mechanism of Alzheimer's progression

UC Santa Barbara neuroscientists uncover mechanism of Alzheimer's progression

Amgen, Novartis collaborate for Alzheimer's disease and migraine programs

Amgen, Novartis collaborate for Alzheimer's disease and migraine programs

Dementia brain imaging is helpful but not definitive, shows new research

Dementia brain imaging is helpful but not definitive, shows new research

Breakthrough discovery provides better understanding of Alzheimer’s disease

Breakthrough discovery provides better understanding of Alzheimer’s disease

Newly discovered prion causes Multiple System Atrophy

Newly discovered prion causes Multiple System Atrophy

Resverlogix presents new data on RVX-208 orally active BET inhibitor at ESC Congress 2015

Resverlogix presents new data on RVX-208 orally active BET inhibitor at ESC Congress 2015

Cholinergic neurons in basal forebrain broadcast message throughout the cerebral cortex

Cholinergic neurons in basal forebrain broadcast message throughout the cerebral cortex

Despite increased life expectancy, British people suffer from more medical ailments

Despite increased life expectancy, British people suffer from more medical ailments

Researchers find fatty acid deposits in brains of Alzheimer's patients

Researchers find fatty acid deposits in brains of Alzheimer's patients

Researchers uncover important cellular functions that help regulate inflammation

Researchers uncover important cellular functions that help regulate inflammation

Brain scans may help predict patients' response to antipsychotic drug treatment

Brain scans may help predict patients' response to antipsychotic drug treatment

Brain cells in Parkinson's disease die prematurely, burning out like an overheating motor

Brain cells in Parkinson's disease die prematurely, burning out like an overheating motor

Alzheimer's Association urges people to participate in ‘Walk to End Alzheimer's’

Alzheimer's Association urges people to participate in ‘Walk to End Alzheimer's’

Experimental gene therapy may prevent neuronal degeneration in patients with Alzheimer's disease

Experimental gene therapy may prevent neuronal degeneration in patients with Alzheimer's disease

Key modifiable Alzheimer’s risk factors pinpointed

Key modifiable Alzheimer’s risk factors pinpointed

Isolated tauopathy ‘surprisingly common’ in AD dementia

Isolated tauopathy ‘surprisingly common’ in AD dementia

Dementia sufferers may begin to lose awareness of memory problems 2-3 years before onset

Dementia sufferers may begin to lose awareness of memory problems 2-3 years before onset

Common gene mutation may cause brain damage associated with ALS and FTD

Common gene mutation may cause brain damage associated with ALS and FTD

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.